• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

USABA becomes finalist for excellence award

Article

Colorado Springs, CO-The El Pomar Foundation has named the United States Association of Blind Athletes as a finalist in the foundation's Awards for Excellence in the Sports and Recreation category. The awards program honors outstanding achievement of Colorado's nonprofit organizations. Each year three finalists are selected in 11 categories. Winners will be named in November.

Colorado Springs, CO-The El Pomar Foundation has named the United States Association of Blind Athletes as a finalist in the foundation's Awards for Excellence in the Sports and Recreation category. The awards program honors outstanding achievement of Colorado's nonprofit organizations. Each year three finalists are selected in 11 categories. Winners will be named in November.

"It is truly an honor to be named a finalist for El Pomar's Awards for Excellence," said Kevin Szott, president of USABA's board of directors. "It is a tribute to the impact made by our athletes, coaches, volunteers, and staff."

Last year nearly 300 blind and visually impaired athletes and an additional 200 support staff came from across the globe for the week-long International Blind Sports Association World Youth Championships in Colorado Springs. The USABA hosted the event.

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
© 2024 MJH Life Sciences

All rights reserved.